The preparations for the CBD epilepsy study were started in December 2018, including hiring a fulltime research assistant and part-time work/study student, creating all of the study documents necessary for the trial, and creating a newsletter/announcement for Colorado veterinarians. We began enrolling patients for the study at the end of January 2018. We anticipated enrolling 20 patients per year; therefore, we are on track with 54 patients in 2 1/2 years.
Research Update from Dr. Stephanie McGrath looking at use of CBD for the treatment of epilepsy.
Research Update from Dr. Volk for supplemental treatment of epilepsy.
Continue reading “Research Update Mid-Year-3 CHF-02252: Investigating a Ketogenic Medium-Chain Triglyceride (MCT) Supplement for the Treatment of Drug-Resistant Canine Idiopathic Epilepsy and Its Behavioral Comorbidities”
Research update for Dr. Johnson’s work looking to identify possible genetic risk factors for canine epilepsy.
Update on progress of Dr. Volk’s work looking at the benefits of using a ketogenic MCT supplement to aid in treatment of dogs with idiopathic canine epilepsy.